McJannet David

CEO David McJannet sold 47,526 shares of HCP at $34.22 on 2024-12-20, reducing holdings 9.3% to 466.0K shares

CEO David McJannet executed a sale of 47,526 shares at $34.22, reducing his position by 9.3% to 465,978 shares post-transaction. This sale occurs near HashiCorp's 52-week high of $34.27, with the stock at $34.24 current price and showing modest positive momentum (+1.2% over 90 days). However, this trade represents a partial reduction from a significant CEO stake, not a full position exit—the filing indicates derivative securities holdings in Form 4 Table II that are not yet populated in the database, meaning the stated 466.0K shares do not represent the insider's total position. Critically, McJannet's prior sell history at HCP shows weak timing execution: across 5 prior sales at this ticker, none achieved positive returns at the 90-day mark, suggesting a pattern of selling at inopportune moments despite the company's 22.5% annual revenue growth. The company remains unprofitable (net income of $-13.0M), which may explain the cautious stance, but the timing track record warrants attention.

CEO David McJannet sold 48,055 shares of HCP at $33.84; still holds 419,531 shares post-transaction.

David McJannet, CEO and Chairman, sold 48,055 shares at $33.84 on 2024-09-20 for $1,626,214.84, representing a 10.3% reduction of his pre-transaction stake of 467,586 shares. This sale occurs near the 52-week high of $33.99 (-0.5% from peak) and follows a pattern in his HCP-specific history: of 5 prior sells at this ticker, only 1 demonstrated favorable 90-day timing. His cross-ticker track record shows 6 prior sells with a 90-day well-timed rate of 33.33%, suggesting mixed execution overall. The sale is notable given the company's fundamental position—HashiCorp posted $165.1M in revenue with annual growth of 22.5%, yet reported a net loss of $26.5M in the latest quarter and remains unprofitable on a full-year basis. The transaction is a derivative conversion event; the insider's complete position including unconverted derivatives is not fully visible in current database records, so this should be assessed as a partial sale of a specific batch rather than a broader position shift.

CEO McJannet sells 48,055 HCP shares at $33.26; maintains 373,330 shares post-sale amid unprofitability

David McJannet, CEO and Chairman, sold 48,055 shares of HashiCorp at $33.26 on 2024-06-20, reducing his holdings from 421,385 to 373,330 shares (an 11.4% reduction). The company reported $160,579,000 in revenue but remains unprofitable with a net loss of $51,128,000 for its most recent full fiscal year, despite achieving 22.5% annual revenue growth. At the same-ticker level, McJannet's prior five sales show mixed timing outcomes: two delivered positive 90-day returns (poorly timed from an insider perspective, as the stock rose after), while three produced negative 90-day returns (better timed, with the stock falling afterward). The current transaction at $33.26 is 1.5% below the 52-week high of $33.99, placing it near peak levels while the company operates at a significant loss.